Home A2Z Synthesis

A2Z Synthesis

In operation
-
Drug Developer for Biological Target Identification
Basic
Enterprise Profile

Basic Information

A2Z Synthesis Fragment-Based Drug Discovery is an efficient and innovative approach for identifying a range of biological targets. Small fragments allow for further chemical optimization by adding new chemical groups or by combining different fragments to form a single molecule.
A2Z Synthesis
--
unclear
--
--

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Gene Technology